2018 was a year of ups and downs for the business and technology community. It was a year of big exits-both IPOs and acquisitions-for tech and life sciences companies. Venture funding remained strong, but more money went to fewer (and later-stage) companies overall. As the year winds down, we’re reflecting on the big innovation trends and developments that will carry over to next year.
Storylines in various sectors helped shape the overall narrative in 2018. Cell and gene therapies, cancer immunotherapy, and digital medicines made substantial progress in healthcare. Artificial intelligence and cybersecurity remained front and center in tech, as new… Read more »
UNDERWRITERS AND PARTNERS